NCT01016002 - Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2011

Conditions

Non-curative Resectable Bile Duct Carcinoma

Interventions

DRUG

Temoporfin

"Drug treatment: Temoporfin 0.15 mg/kg body weight, intravenous injection within at least 6 min.~Laser Treatment: 652nm wavelength; 30 Joules/cm diffusor length ( 200 sec at 150mW/cm diffusor length), within 96 h after Foscan"

Trial Locations (2)

5020

RECRUITING

Department of Internal Medicine I, Paracelsus Medical University Salzburg, Salzburg

20246

RECRUITING

Internal Medicine Dept., University Medical Center Hamburg-Eppendorf, Hamburg